These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9412701)

  • 1. Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group.
    Stewart GJ; Ashton LJ; Biti RA; Ffrench RA; Bennetts BH; Newcombe NR; Benson EM; Carr A; Cooper DA; Kaldor JM
    AIDS; 1997 Dec; 11(15):1833-8. PubMed ID: 9412701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
    Bratt G; Leandersson AC; Albert J; Sandström E; Wahren B
    AIDS; 1998 May; 12(7):729-36. PubMed ID: 9619804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression.
    Xiao L; Rudolph DL; Owen SM; Spira TJ; Lal RB
    AIDS; 1998 Sep; 12(13):F137-43. PubMed ID: 9764773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.
    Morawetz RA; Rizzardi GP; Glauser D; Rutschmann O; Hirschel B; Perrin L; Opravil M; Flepp M; von Overbeck J; Glauser MP; Ghezzi S; Vicenzi E; Poli G; Lazzarin A; Pantaleo G
    Eur J Immunol; 1997 Dec; 27(12):3223-7. PubMed ID: 9464809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group.
    Clegg AO; Ashton LJ; Biti RA; Badhwar P; Williamson P; Kaldor JM; Stewart GJ
    AIDS; 2000 Jan; 14(2):103-8. PubMed ID: 10708279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between CCR5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Koot M; Cornelissen M; Keet IP; Brouwer M; Broersen SM; Bakker M; Roos MT; Prins M; de Wolf F; Coutinho RA; Miedema F; Goudsmit J; Schuitemaker H
    Ann Intern Med; 1997 Nov; 127(10):882-90. PubMed ID: 9382366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of MT-2 tropism on the prognostic implications of the delta32 deletion in the CCR-5 gene.
    Bratt G; Sandström E; Albert J; Samson M; Wahren B
    AIDS; 1997 Oct; 11(12):1415-9. PubMed ID: 9342063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
    Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
    Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.
    Meijerink H; Indrati AR; van Crevel R; Joosten I; Koenen H; van der Ven AJ
    BMC Infect Dis; 2014 Dec; 14():683. PubMed ID: 25495598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
    Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
    J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.
    Rodés B; Toro C; Paxinos E; Poveda E; Martinez-Padial M; Benito JM; Jimenez V; Wrin T; Bassani S; Soriano V
    AIDS; 2004 May; 18(8):1109-16. PubMed ID: 15166526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors.
    Walli R; Reinhart B; Luckow B; Lederer E; Loch O; Malo A; Wank R; Schlöndorff D; Goebel FD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):229-33. PubMed ID: 9665499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection.
    Carotenuto P; Looij D; Keldermans L; de Wolf F; Goudsmit J
    AIDS; 1998 Sep; 12(13):1591-600. PubMed ID: 9764777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors.
    Menzo S; Sampaolesi R; Vicenzi E; Santagostino E; Liuzzi G; Chirianni A; Piazza M; Cohen OJ; Bagnarelli P; Clementi M
    AIDS; 1998 Jun; 12(9):985-97. PubMed ID: 9662194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.
    Meyer L; Magierowska M; Hubert JB; Rouzioux C; Deveau C; Sanson F; Debre P; Delfraissy JF; Theodorou I
    AIDS; 1997 Sep; 11(11):F73-8. PubMed ID: 9302436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between a defective CCR-5 gene and progression to disease in HIV infection.
    Balfe P; Churcher Y; Penny M; Easterbrook PJ; Goodall RL; Galpin S; Gotch F; Daniels RS; McKeating JA
    AIDS Res Hum Retroviruses; 1998 Sep; 14(14):1229-34. PubMed ID: 9764905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the CCR5 and CXCR4 genes (HIV-1 co-receptors) in resistance to HIV-1 infection and AIDS development among intravenous drug users.
    Alvarez V; López-Larrea C; Coto E
    Hum Genet; 1998 Apr; 102(4):483-6. PubMed ID: 9600249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010.
    Mandalia S; Westrop SJ; Beck EJ; Nelson M; Gazzard BG; Imami N
    PLoS One; 2012; 7(2):e29844. PubMed ID: 22363409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of a CCR5 defective allele in pediatric HIV-1 infection.
    Romiti ML; Colognesi C; Cancrini C; Mas A; Berrino M; Salvatori F; Orlandi P; Jansson M; Palomba E; Plebani A; Bertran JM; Hernandez M; de Martino M; Amoroso A; Tovo PA; Rossi P; Espanol T; Scarlatti G
    Mol Med; 2000 Jan; 6(1):28-36. PubMed ID: 10803406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India.
    Swathirajan CR; Vignesh R; Waldrop G; Shanmugasundaram U; Nandagopal P; Solomon SS; Pradeep A; Saravanan S; Murugavel KG
    Curr HIV Res; 2018; 16(4):302-314. PubMed ID: 30543175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.